Anti-IL-13Ra1/CD213a1 Antibody (MK-6105)
Catalog No.
F1691
Anti-IL-13Ra1/CD213a1 Antibody (MK-6105)
Featured Products
Eblasakimab (MK-6105) is a CHO-expressed humanized antibody targeting IL-13Ra1/CD213a1. Eblasakimab (MK-6105) has a huIgG2-type heavy chain and a huκ-type light chain, with a predicted molecular weight (MW) of 124.7 kDa.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
124.7 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
10G5, 10G5H6, ASLAN004
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P78552
Human
Unconjugated
Monoclonal
Protein A
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-13Ra1 / CD213a1
Please avoid freeze-thaw cycles.